Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain

Sexually Transmitted Infections

Volumn 88, Issue 3, 2012, Pages 212-217

  Johnson, Anne M ^a   Mercer, Catherine H ^a   Beddows, Simon ^b   De Silva, Natasha ^b   Desai, Sarika ^b   Howell Jones, Rebecca ^b   Carder, Caroline ^c   Sonnenberg, Pam ^a   Fenton, Kevin A ^a   Lowndes, Catherine ^b   Soldan, Kate ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONDOM; FEMALE; GENOTYPE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SEXUALLY TRANSMITTED DISEASES, VIRAL; URINE; YOUNG ADULT;

EID: 84860345501     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050306     Document Type: Article

References (26)

1. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27. (Pubitemid 36159887)
2. Muñoz N, Castellsagué X, de González AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24(Suppl 3):S3/1-10.
3. Bouvard V, Baan R, Straif K, et al. A review of human carcinogensdPart B: Biological agents. Lancet Oncol 2009;10:321-2.
4. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24 (Suppl 3):S3/11-25.
5. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011;128:927-35.
6. Vandepapeliere P, Barrasso R, Meijer CJ, et al. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: Infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis 2005;192:2099-107. (Pubitemid 41779207)
7. Health Protection Agency. STI Annual Data Tables 2009. 2011. http://www.hpa. org.uk/stiannualdatatables/ (accessed 29 Nov 2011).
8. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
9. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 2006;367:1247-55.
10. Jit M, Choi YH, Edmunds WJ. Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ 2008;337:a769.
11. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: Partnerships, practices, and HIV risk behaviours. Lancet 2001;358:1835-42. (Pubitemid 34008648)
12. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: Reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001;358:1851-4. (Pubitemid 34008651)
13. Bissett SL, Howell-Jones R, Swift C, et al. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 2011;83:1744-51.
14. Stata Statistical Software: Release 10 [Computer Program]. College Station, TX, USA: StataCorp LP, 2007.
15. Mercer CH, Wellings K, Macdowall W, et al. First sexual partnerships: Age differences and their significance. Empirical evidence from the 2000 British National Survey of Sexual Attitudes and Lifestyles ('Natsal 2000'). J Adolesc Health 2006;39:87-95. (Pubitemid 43867351)
16. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-19. (Pubitemid 46333946)
17. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006;194:1044-57. (Pubitemid 44547644)
18. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004;189:677-85. (Pubitemid 38270922)
19. Daponte A, Pournaras S, Mademtzis I, et al. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol 2006;36:189-93. (Pubitemid 43866595)
20. Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011;377:932-40. Erratum in: Lancet 2011;377:2006.
21. Howell-Jones R, Bailey A, Beddows S, et al. Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer 2010;103:209-16.
22. Appleby P, Beral V, Berrington de GA, et al. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-95.
23. Johnson AM, Wadsworth J, Wellings K, et al. Sexual Attitudes and Lifestyles. Oxford: Blackwell Scientific Publications, 1994.
24. Aicken CR, Nardone A, Mercer CH. Alcohol misuse, sexual risk behaviour and adverse sexual health outcomes: Evidence from Britain's national probability sexual behaviour surveys. J Public Health (Oxf) 2010;33:262-71.
25. Mehanna H, Jones TM, Gregoire V, et al. Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010;340:c1439.
26. Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/ 18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-14.